Sunshine Biopharma Inc. SBFM
$1.28
+3.23%
at last close
Analyst Consensus
- Consensus Rating
- Buy (1 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $7.00
- Implied Upside
- +446.9%
- Price Target Range
- $7.00 – $7.00
- Analysts (12 mo)
- 1
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2025-10-08 | Aegis CapitalDavid Bouchey |
Reiterates | Buy | $7 |
| 2024-12-05 | Aegis CapitalDavid Bouchey |
Reiterates | Buy | $15 |
| 2023-08-07 | Aegis CapitalDavid Bouchey |
Initiates coverage on | Buy | $5200 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $1.28
- Market Cap
- $4.81 million
- 52-Week Range
- $1.01 – $24.30
- Average Volume
- 951K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.